2076975 2077203
최종편집 2024-10-14 11:37 (월)
처음으로 회원가입 전체기사
기사 (249건)
리스트형 웹진형 타일형
[e_newsmp] AbbVie strengthens leadership in autoimmune disease market
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-03-08 17:15
[e_newsmp] KOSPI pharmaceuticals market cap dropped by KRW 5.7 trillion in February alone
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-03-02 16:01
[e_newsmp] Reba-eyeㆍReva-K get insurance benefit, Ameliebou down 24.5%
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-03-02 00:31
[e_newsmp] Chronic Hepatitis B treatmentㆍSkyrizi get expanded insurance benefits, Reva-K receives new benefit
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-02-23 01:00
[e_newsmp] Pharmaceutical companies reach an average sales growth rate of 13.4%
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-02-16 17:38
[e_newsmp] “Nabota has no impact on overseas export and sales”
Hyeokgi Lee, Newsmp | 2023-02-14 23:44
[e_newsmp] Semaglutide’s golden age, Ozempic annual sales reach KRW 1 trillion
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-02-09 17:21
[e_newsmp] “Xpovio, the only hope for patients with multiple myeloma who have exhausted all treatments”
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-02-07 17:21
[e_newsmp] Market cap of KOSPI pharmaceutical index dropped by KRW 2.4481 trillion in January
Hyeokgi Lee, Newsmp | 2023-02-02 14:12
[e_newsmp] LucentisㆍVenclexta benefits cut by 30% and 12.2%, Vfend increases by 19.5%
Hyeokgi Lee, Newsmp | 2023-01-31 23:30
[e_newsmp] Atopic dermatitis treatment Dupixent gets insurance coverage recognition for children and adolescents
Hyeokgi Lee, Newsmp | 2023-01-26 11:58
[e_newsmp] BeiGene Korea general manager Yang Ji-hye
Jaehoon SongㆍHyeokgi Lee, Newsmp | 2023-01-25 16:14
[e_newsmp] SGLT2 inhibitors occupy a third of the K-Orange Book in 2022
Hyeokgi Lee, Newsmp | 2023-01-19 19:54
[e_newsmp] One-fifth of KOSDAQ pharmaceuticals plunged more than 50% last year
Hyeokgi Lee, Newsmp | 2023-01-17 23:54
[e_newsmp] AstraZeneca registered highest number of patents in Korea in 2022
Hyeokgi Lee, Newsmp | 2023-01-11 01:13
[e_newsmp] Cold medicine price index balloons by 13.2%, anti-inflammatory drug by 7.1%
Hyeokgi Lee, Newsmp | 2023-01-05 17:35
[e_newsmp] Five drugmakers enter the top 100 best growth in 2022 on KOSPI
Hyeokgi Lee, Newsmp | 2023-01-03 14:02
[e_newsmp] Benefits for AjovyㆍLucen-BSㆍAmeliebou are granted, 25% cut in Revlimid
Hyeokgi Lee, Newsmp | 2022-12-29 11:56
[e_newsmp] AjovyㆍDovprela win insurance benefits, PraluentㆍRepathaㆍK-CAB expand
Hyeokgi Lee, Newsmp | 2022-12-27 17:13
[e_newsmp] Pfizer Korea “Advocate for pro-innovation and pro-patient policies”
Hyeokgi Lee & Jaehoon Song, Newsmp | 2022-12-23 10:06